We are live on ! Find out more
VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

47 hedge funds and large institutions have $28M invested in Viracta Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

184% more call options, than puts

Call options by funds: $88K | Put options by funds: $31K

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

43% more capital invested

Capital invested by funds: $19.6M → $28M (+$8.38M)

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

7% more funds holding

Funds holding: 44 → 47 (+3)

Holders
47
Holders Change
+3
Holders Change %
+6.82%
% of All Funds
1.04%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.11%
New
11
Increased
9
Reduced
7
Closed
7
Calls
$88K
Puts
$31K
Net Calls
+$57K
Net Calls Change
+$20K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$2.22M
2
CA
Corriente Advisors
Texas
+$1.87M
3
APM
Avidity Partners Management
Texas
+$1.8M
4
BlackRock
BlackRock
New York
+$699K
5
NCM
Nantahala Capital Management
Connecticut
+$497K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$881K
2
Wells Fargo
Wells Fargo
California
-$219K
3
Two Sigma Investments
Two Sigma Investments
New York
-$151K
4
BL
Bleichroeder LP
New York
-$99K
5
Millennium Management
Millennium Management
New York
-$65K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$22K +$8.66K +399 +37%
Creative Planning
27
Creative Planning
Kansas
$21K +$31K +1,429 New
BFM
28
Boothbay Fund Management
New York
$20K – – –
Victory Capital Management
29
Victory Capital Management
Texas
$16K +$22.7K +1,046 New
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$10K -$15.8K -728 -52%
Wolverine Trading
31
Wolverine Trading
Illinois
$10K +$14.4K +665 New
Two Sigma Advisers
32
Two Sigma Advisers
New York
$8K -$44K -2,028 -78%
Bank of America
33
Bank of America
North Carolina
$8K – – –
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$8K – – –
JMPWA
35
JP Morgan Private Wealth Advisors
California
$8K +$12.4K +571 New
State Street
36
State Street
Massachusetts
$5K – – –
Morgan Stanley
37
Morgan Stanley
New York
$2K -$5.73K -264 -63%
BWP
38
Baldwin Wealth Partners
Massachusetts
$1K – – –
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$1K +$1.58K +73 New
Two Sigma Investments
40
Two Sigma Investments
New York
– -$151K -12,790 Closed
BL
41
Bleichroeder LP
New York
– -$99K -8,414 Closed
Millennium Management
42
Millennium Management
New York
– -$65K -5,508 Closed
AG
43
Algert Global
California
– -$23K -1,915 Closed
ECM
44
ExodusPoint Capital Management
New York
– -$5K -423 Closed
Jane Street
45
Jane Street
New York
– -$4K -304 Closed
Simplex Trading
46
Simplex Trading
Illinois
– -$1.87K -86 Closed
PFGIA
47
Patriot Financial Group Insurance Agency
Massachusetts
– -$43 -2 -29%
MWM
48
MBE Wealth Management
Wisconsin
– +$109 +5 New
Osaic Holdings
49
Osaic Holdings
Arizona
– +$521 +24 New
SMH
50
Sanders Morris Harris
Texas
– +$12.4K +571 New
1
2

VIRX Hedge Fund Activity: Q1 2020 in Review

47 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Viracta Therapeutics, Inc. Common Stock (VIRX) for Q1 2020, worth a combined $28M — up 43% from $19.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new VIRX positions and 7 closed out — a net gain of 4 holders — while 9 added to existing stakes and 7 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $2.22M. The largest seller was Sphera Funds Management, cutting an estimated $881K.

  • 47 institutional investors held Viracta Therapeutics, Inc. Common Stock (VIRX) as of Q1 2020, up from 44 in Q4 2019.
  • Funds reported $28M of Viracta Therapeutics, Inc. Common Stock stock for Q1 2020, up 43% quarter-over-quarter.
  • 11 funds opened new Viracta Therapeutics, Inc. Common Stock positions in Q1 2020 and 7 closed out, a net change of +4 holders.
  • The largest Viracta Therapeutics, Inc. Common Stock buyer in Q1 2020 was Citadel Advisors, an estimated $2.22M added.
  • The largest Viracta Therapeutics, Inc. Common Stock seller in Q1 2020 was Sphera Funds Management, an estimated $881K sold.

Based on aggregated 13F filings for Q1 2020.